Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)
0.4550
-0.0150 (-3.19%)
May 13, 2025, 4:08 PM HKT
HKG:8189 Revenue
In the year 2024, Tianjin TEDA Biomedical Engineering Company had annual revenue of 385.48M CNY, down -3.14%.
Revenue
385.48M CNY
Revenue Growth
-14.32%
P/S Ratio
2.37
Revenue / Employee
1.48M CNY
Employees
260
Market Cap
970.92M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 385.48M | -12.52M | -3.14% |
Dec 31, 2023 | 398.00M | -5.73M | -1.42% |
Dec 31, 2022 | 403.73M | -72.66M | -15.25% |
Dec 31, 2021 | 476.38M | 107.03M | 28.98% |
Dec 31, 2020 | 369.36M | 10.60M | 2.96% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Zijin Mining Group Company | 330.00B |
CMOC Group | 228.28B |
China Hongqiao Group | 166.19B |
Anhui Conch Cement Company | 95.16B |
Aluminum Corporation of China | 261.49B |
Zhaojin Mining Industry Company | 13.52B |
Jiangxi Copper Company | 546.83B |
United Company RUSAL, International Public Joint-Stock Company | 93.85B |